WARTS
Clinical trials for WARTS explained in plain language.
Never miss a new study
Get alerted when new WARTS trials appear
Sign up with your email to follow new studies for WARTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug aims to fix faulty immune system in rare disorder
Disease control Recruiting nowThis study is testing whether Mozobil, a drug already used for other conditions, can safely improve low white blood cell counts in adults with WHIMS syndrome. WHIMS is a rare genetic disorder where the immune system doesn't work properly, leading to frequent infections, warts, an…
Matched conditions: WARTS
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New wart treatment seeks final approval in major trial
Disease control Recruiting nowThis study is testing a topical liquid called YCANTH to see if it can safely and effectively clear common warts. About 300 people aged 2 and up with common warts will have the treatment or a placebo applied to their warts every few weeks. The main goal is to see how many people h…
Matched conditions: WARTS
Phase: PHASE3 • Sponsor: Verrica Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Scientists track mysterious immune deficiency for clues
Knowledge-focused Recruiting nowThis study aims to understand a rare condition where people have very low levels of a key immune cell (CD4+ T cells) without having HIV. Researchers will follow about 950 participants, including patients and their family members, for 4 to 20 years to learn what causes the conditi…
Matched conditions: WARTS
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC